Lupin launches Risperidone extended-release injectable suspension in the U.S. with 180-day CGT exclusivity
November 14, 2025
- Rajasthan bans private practice for Principals, Superintendents of Govt Medical Colleges
- Medicxi closes fifth fund to back ‘asset-centric’ startups
- Rapid Nexus Reports the US FDA’s 510(k) Clearance of Hemastyl Gel Device to Support Wound Healing
- MP DME begins stray vacancy round choice filling for 60 vacant seats
Headlines
